{"url_path":"/sec/sls/8-k/2026-06-25/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ****Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-25","source_url":"https://www.sec.gov/Archives/edgar/data/1390478/0001104659-26-077556-index.html","accession_number":"0001104659-26-077556","cik":"0001390478","ticker":"SLS","issuer_name":"SELLAS Life Sciences Group, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1390478/0001104659-26-077556-index.html","primary_entity_key":"0001390478","primary_entity_name":"SELLAS Life Sciences Group, Inc."},"word_count":149,"has_tables":true,"body_markdown":"**Item 9.01.****Financial Statements and Exhibits.**\n\n \n\n(d)       Exhibits\n\n \n\nExhibit Number \nDescription\n\n[10.1](tm2618927d1_ex10-1.htm) \n[Amendment to Employment Agreement by and between the Company and Dr. Angelos Stergiou, dated as of June 24, 2026.](tm2618927d1_ex10-1.htm)\n\n[10.2](tm2618927d1_ex10-2.htm) \n[Amended and Restated Severance and Change of Control Letter Agreement by and between the Company and John Burns, dated as of June 24, 2026.](tm2618927d1_ex10-2.htm)\n\n[10.3](tm2618927d1_ex10-3.htm) \n[Amended and Restated Severance and Change of Control Letter Agreement by and between the Company and Dr. Dragan Cicic, dated as of June 24, 2026.](tm2618927d1_ex10-3.htm)\n\n104 \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n** **\n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**SELLAS Life Sciences Group, Inc.**\n\n \n \n \n \n\n \n \n \n \n\nDate: June 25, 2026\nBy:\n/s/ John T. Burns\n\n \n \n \nName:\nJohn T. Burns\n\n \n \n \nTitle:\nSenior Vice President, Chief Financial Officer"}